That's what all small biotechs do in the beginning out of necessity. If they need the money to finance a new treatment then it's justified. Sorry for those that bought at a higher price recently but the price will come back. Just hold on. Anyway I got in at 1.5 this morning. Looks like a good entry point or time to average down.
Market Data 
Markets 
AI
